Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Matteo Pirro"'
Publikováno v:
Clinical Reviews in Allergy & Immunology
Familial hypercholesterolemia (FH) is the most common inherited form of dyslipidemia and a major cause of premature cardiovascular disease. Management of FH mainly relies on the efficiency of treatments that reduce plasma low-density lipoprotein (LDL
Autor:
George E. Barreto, Antonio M. Gotto, Amirhossein Sahebkar, Matteo Pirro, Sarvenaz Sabouri-Rad, Amir Abbas Momtazi-Borojeni, Zuhier Awan, Maciej Banach
Publikováno v:
European heart journal. Cardiovascular pharmacotherapy. 5(4)
Proprotein convertase subtilisin/kexin Type 9 (PCSK9) is now identified as an important and major player in hypercholesterolaemia and atherosclerosis pathophysiology. PCSK9, through promoting lysosomal degradation of hepatic low-density lipoprotein (
Autor:
Maciej Banach, Gerald F. Watts, Amirhossein Sahebkar, Vanessa Bianconi, Matteo Pirro, Luis E. Simental-Mendía
Publikováno v:
Journal of Clinical Medicine, Vol 8, Iss 1, p 118 (2019)
Journal of Clinical Medicine
Journal of Clinical Medicine
Aim. To evaluate by meta-analysis of interventional studies the effect of statin therapy on arterial wall inflammation. Background. Arterial exposure to low-density lipoprotein (LDL) cholesterol levels is responsible for initiation and progression of
Autor:
Gerald F. Watts, Luis E. Simental-Mendía, Matteo Pirro, Maciej Banach, Khalid Al-Rasadi, Cesare Sirtori, Stephen L. Atkin, Amirhossein Sahebkar
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
The aim of this meta-analysis of randomized placebo-controlled clinical trials was to assess the effect of ezetimibe on plasma lipoprotein(a) concentrations. Only randomized placebo-controlled trials investigating the impact of ezetimibe treatment on
Autor:
Massimo Raffaele Mannarino, Amirhossein Sahebkar, Franco Baldelli, Andrea Spinozzi, Elisabetta Schiaroli, Francesco Barsotti, Francesco Bagaglia, Matteo Pirro, Daniela Francisci, Vanessa Bianconi
Publikováno v:
Atherosclerosis. 280
Background and aims Despite hypercholesterolemia has been recognized to increase cardiovascular risk in human immunodeficiency virus (HIV)-infected patients, cholesterol-lowering therapy is underused in this population, due to fear of drug-drug inter
Autor:
Maciej Banach, Luis E. Simental-Mendía, Stephen L. Atkin, Matteo Pirro, Amirhossein Sahebkar, Antonio M. Gotto
Background Soy supplementation has been shown to reduce total and low-density lipoprotein cholesterol, while increasing high-density lipoprotein cholesterol. However, contradictory effects of soy isoflavone supplementation on lipoprotein(a) [Lp(a)] h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b2c73873839d3789f21007678606903
http://hdl.handle.net/11391/1439119
http://hdl.handle.net/11391/1439119
Autor:
Vanessa Bianconi, Amirhossein Sahebkar, Željko Reiner, Luis E. Simental-Mendía, Mario Simental-Mendía, Matteo Pirro, Petri T. Kovanen
Publikováno v:
Pharmacological research. 122
Orlistat, an inhibitor of intestinal lipase, promotes body weight reduction. The lipid-lowering efficacy of orlistat is controversial and the effect of orlistat-induced body weight reduction on lipid changes has not been explored in meta-regression a
Autor:
Maciej Banach, Amirhossein Sahebkar, Thomas P. Johnston, Tiziana Bacchetti, Gianna Ferretti, Matteo Pirro
Publikováno v:
Journal of cellular physiology. 233(4)
Lipoprotein(a) Lp(a) is a cholesterol-rich, LDL-like particle that is independently associated with an increased risk for ischemic heart disease, atherosclerosis, thrombosis, and stroke. Genetic variation in the Lp(a) locus and some other genes relat
Autor:
Amirhossein Sahebkar, Massimo Raffaele Mannarino, Matteo Pirro, Vanessa Bianconi, Francesco Bagaglia, Francesco Paciullo
Lipoprotein(a) [Lp(a)] is an enigmatic lipoprotein whose ancestral useful properties have been gradually obscured by its adverse pro-atherogenic and pro-thrombotic effects, that culminate into an increased risk of ischemic cardiovascular events. Alth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a600e0a184a1723b1bab506a29be076a
http://hdl.handle.net/11391/1415084
http://hdl.handle.net/11391/1415084